Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium
Lee, Matthew D; Patel, Sohil H; Mohan, Suyash; Akbari, Hamed; Bakas, Spyridon; Nasrallah, MacLean P; Calabrese, Evan; Rudie, Jeffrey; Villanueva-Meyer, Javier; LaMontagne, Pamela; Marcus, Daniel S; Colen, Rivka R; Balana, Carmen; Choi, Yoon Seong; Badve, Chaitra; Barnholtz-Sloan, Jill S; Sloan, Andrew E; Booth, Thomas C; Palmer, Joshua D; Dicker, Adam P; Flanders, Adam E; Shi, Wenyin; Griffith, Brent; Poisson, Laila M; Chakravarti, Arnab; Mahajan, Abhishek; Chang, Susan; Orringer, Daniel; Davatzikos, Christos; Jain, Rajan
PURPOSE/OBJECTIVE:While the T2-FLAIR mismatch sign is highly specific for isocitrate dehydrogenase (IDH)-mutant, 1p/19q-noncodeleted astrocytomas among lower-grade gliomas, its utility in WHO grade 4 gliomas is not well-studied. We derived the partial T2-FLAIR mismatch sign as an imaging biomarker for IDH mutation in WHO grade 4 gliomas. METHODS:Preoperative MRI scans of adult WHO grade 4 glioma patients (n = 2165) from the multi-institutional ReSPOND (Radiomics Signatures for PrecisiON Diagnostics) consortium were analyzed. Diagnostic performance of the partial T2-FLAIR mismatch sign was evaluated. Subset analyses were performed to assess associations of imaging markers with overall survival (OS). RESULTS:One hundred twenty-one (5.6%) of 2165 grade 4 gliomas were IDH-mutant. Partial T2-FLAIR mismatch was present in 40 (1.8%) cases, 32 of which were IDH-mutant, yielding 26.4% sensitivity, 99.6% specificity, 80.0% positive predictive value, and 95.8% negative predictive value. Multivariate logistic regression demonstrated IDH mutation was significantly associated with partial T2-FLAIR mismatch (odds ratio [OR] 5.715, 95% CI [1.896, 17.221], p = 0.002), younger age (OR 0.911 [0.895, 0.927], p < 0.001), tumor centered in frontal lobe (OR 3.842, [2.361, 6.251], p < 0.001), absence of multicentricity (OR 0.173, [0.049, 0.612], p = 0.007), and presence of cystic (OR 6.596, [3.023, 14.391], p < 0.001) or non-enhancing solid components (OR 6.069, [3.371, 10.928], p < 0.001). Multivariate Cox analysis demonstrated cystic components (p = 0.024) and non-enhancing solid components (p = 0.003) were associated with longer OS, while older age (p < 0.001), frontal lobe center (p = 0.008), multifocality (p < 0.001), and multicentricity (p < 0.001) were associated with shorter OS. CONCLUSION/CONCLUSIONS:Partial T2-FLAIR mismatch sign is highly specific for IDH mutation in WHO grade 4 gliomas.
PMID: 37468750
ISSN: 1432-1920
CID: 5535892
Federated learning enables big data for rare cancer boundary detection
Pati, Sarthak; Baid, Ujjwal; Edwards, Brandon; Sheller, Micah; Wang, Shih-Han; Reina, G Anthony; Foley, Patrick; Gruzdev, Alexey; Karkada, Deepthi; Davatzikos, Christos; Sako, Chiharu; Ghodasara, Satyam; Bilello, Michel; Mohan, Suyash; Vollmuth, Philipp; Brugnara, Gianluca; Preetha, Chandrakanth J; Sahm, Felix; Maier-Hein, Klaus; Zenk, Maximilian; Bendszus, Martin; Wick, Wolfgang; Calabrese, Evan; Rudie, Jeffrey; Villanueva-Meyer, Javier; Cha, Soonmee; Ingalhalikar, Madhura; Jadhav, Manali; Pandey, Umang; Saini, Jitender; Garrett, John; Larson, Matthew; Jeraj, Robert; Currie, Stuart; Frood, Russell; Fatania, Kavi; Huang, Raymond Y; Chang, Ken; Quintero, Carmen Balaña; Capellades, Jaume; Puig, Josep; Trenkler, Johannes; Pichler, Josef; Necker, Georg; Haunschmidt, Andreas; Meckel, Stephan; Shukla, Gaurav; Liem, Spencer; Alexander, Gregory S; Lombardo, Joseph; Palmer, Joshua D; Flanders, Adam E; Dicker, Adam P; Sair, Haris I; Jones, Craig K; Venkataraman, Archana; Jiang, Meirui; So, Tiffany Y; Chen, Cheng; Heng, Pheng Ann; Dou, Qi; Kozubek, Michal; Lux, Filip; Michálek, Jan; Matula, Petr; Keřkovský, Miloš; Kopřivová, Tereza; Dostál, Marek; Vybíhal, Václav; Vogelbaum, Michael A; Mitchell, J Ross; Farinhas, Joaquim; Maldjian, Joseph A; Yogananda, Chandan Ganesh Bangalore; Pinho, Marco C; Reddy, Divya; Holcomb, James; Wagner, Benjamin C; Ellingson, Benjamin M; Cloughesy, Timothy F; Raymond, Catalina; Oughourlian, Talia; Hagiwara, Akifumi; Wang, Chencai; To, Minh-Son; Bhardwaj, Sargam; Chong, Chee; Agzarian, Marc; Falcão, Alexandre Xavier; Martins, Samuel B; Teixeira, Bernardo C A; Sprenger, Flávia; Menotti, David; Lucio, Diego R; LaMontagne, Pamela; Marcus, Daniel; Wiestler, Benedikt; Kofler, Florian; Ezhov, Ivan; Metz, Marie; Jain, Rajan; Lee, Matthew; Lui, Yvonne W; McKinley, Richard; Slotboom, Johannes; Radojewski, Piotr; Meier, Raphael; Wiest, Roland; Murcia, Derrick; Fu, Eric; Haas, Rourke; Thompson, John; Ormond, David Ryan; Badve, Chaitra; Sloan, Andrew E; Vadmal, Vachan; Waite, Kristin; Colen, Rivka R; Pei, Linmin; Ak, Murat; Srinivasan, Ashok; Bapuraj, J Rajiv; Rao, Arvind; Wang, Nicholas; Yoshiaki, Ota; Moritani, Toshio; Turk, Sevcan; Lee, Joonsang; Prabhudesai, Snehal; Morón, Fanny; Mandel, Jacob; Kamnitsas, Konstantinos; Glocker, Ben; Dixon, Luke V M; Williams, Matthew; Zampakis, Peter; Panagiotopoulos, Vasileios; Tsiganos, Panagiotis; Alexiou, Sotiris; Haliassos, Ilias; Zacharaki, Evangelia I; Moustakas, Konstantinos; Kalogeropoulou, Christina; Kardamakis, Dimitrios M; Choi, Yoon Seong; Lee, Seung-Koo; Chang, Jong Hee; Ahn, Sung Soo; Luo, Bing; Poisson, Laila; Wen, Ning; Tiwari, Pallavi; Verma, Ruchika; Bareja, Rohan; Yadav, Ipsa; Chen, Jonathan; Kumar, Neeraj; Smits, Marion; van der Voort, Sebastian R; Alafandi, Ahmed; Incekara, Fatih; Wijnenga, Maarten M J; Kapsas, Georgios; Gahrmann, Renske; Schouten, Joost W; Dubbink, Hendrikus J; Vincent, Arnaud J P E; van den Bent, Martin J; French, Pim J; Klein, Stefan; Yuan, Yading; Sharma, Sonam; Tseng, Tzu-Chi; Adabi, Saba; Niclou, Simone P; Keunen, Olivier; Hau, Ann-Christin; Vallières, Martin; Fortin, David; Lepage, Martin; Landman, Bennett; Ramadass, Karthik; Xu, Kaiwen; Chotai, Silky; Chambless, Lola B; Mistry, Akshitkumar; Thompson, Reid C; Gusev, Yuriy; Bhuvaneshwar, Krithika; Sayah, Anousheh; Bencheqroun, Camelia; Belouali, Anas; Madhavan, Subha; Booth, Thomas C; Chelliah, Alysha; Modat, Marc; Shuaib, Haris; Dragos, Carmen; Abayazeed, Aly; Kolodziej, Kenneth; Hill, Michael; Abbassy, Ahmed; Gamal, Shady; Mekhaimar, Mahmoud; Qayati, Mohamed; Reyes, Mauricio; Park, Ji Eun; Yun, Jihye; Kim, Ho Sung; Mahajan, Abhishek; Muzi, Mark; Benson, Sean; Beets-Tan, Regina G H; Teuwen, Jonas; Herrera-Trujillo, Alejandro; Trujillo, Maria; Escobar, William; Abello, Ana; Bernal, Jose; Gómez, Jhon; Choi, Joseph; Baek, Stephen; Kim, Yusung; Ismael, Heba; Allen, Bryan; Buatti, John M; Kotrotsou, Aikaterini; Li, Hongwei; Weiss, Tobias; Weller, Michael; Bink, Andrea; Pouymayou, Bertrand; Shaykh, Hassan F; Saltz, Joel; Prasanna, Prateek; Shrestha, Sampurna; Mani, Kartik M; Payne, David; Kurc, Tahsin; Pelaez, Enrique; Franco-Maldonado, Heydy; Loayza, Francis; Quevedo, Sebastian; Guevara, Pamela; Torche, Esteban; Mendoza, Cristobal; Vera, Franco; Ríos, Elvis; López, Eduardo; Velastin, Sergio A; Ogbole, Godwin; Soneye, Mayowa; Oyekunle, Dotun; Odafe-Oyibotha, Olubunmi; Osobu, Babatunde; Shu'aibu, Mustapha; Dorcas, Adeleye; Dako, Farouk; Simpson, Amber L; Hamghalam, Mohammad; Peoples, Jacob J; Hu, Ricky; Tran, Anh; Cutler, Danielle; Moraes, Fabio Y; Boss, Michael A; Gimpel, James; Veettil, Deepak Kattil; Schmidt, Kendall; Bialecki, Brian; Marella, Sailaja; Price, Cynthia; Cimino, Lisa; Apgar, Charles; Shah, Prashant; Menze, Bjoern; Barnholtz-Sloan, Jill S; Martin, Jason; Bakas, Spyridon
Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to various limitations. Federated ML (FL) provides an alternative paradigm for accurate and generalizable ML, by only sharing numerical model updates. Here we present the largest FL study to-date, involving data from 71 sites across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, reporting the largest such dataset in the literature (n = 6, 314). We demonstrate a 33% delineation improvement for the surgically targetable tumor, and 23% for the complete tumor extent, over a publicly trained model. We anticipate our study to: 1) enable more healthcare studies informed by large diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further analyses for glioblastoma by releasing our consensus model, and 3) demonstrate the FL effectiveness at such scale and task-complexity as a paradigm shift for multi-site collaborations, alleviating the need for data-sharing.
PMCID:9722782
PMID: 36470898
ISSN: 2041-1723
CID: 5381682